Biography

Joshua P. Davis is a Shareholder at Berger Montague, where he supervises the Firm’s San Francisco Bay Area office. He focuses his practice on antitrust, appeals, class certification, and complex litigation ethics. Mr. Davis is one of the nation’s leading scholars on antitrust procedure, class certification, and ethics in class actions and complex litigation. He has won a unanimous decision before the U.S. Supreme Court, was a member of the trial team that secured a $442 million antitrust judgment, and is the lead author and editor of the first treatise dedicated to ethics in class actions and multidistrict litigation.

Mr. Davis has achieved significant appellate victories. He argued Harrow v. Department of Defense, No. 23-21, before the U.S. Supreme Court and obtained a 9-0 decision in Mr. Harrow’s favor (May 16, 2024), for which the National Civil Justice Institute honored him with its 2025 Appellate Advocacy Award. In Innovative Health, LLC v. Biosense Webster, Inc., he persuaded the U.S. Court of Appeals for the Ninth Circuit to reverse summary judgment for Biosense Webster, reviving the antitrust claims that the Firm later tried to a favorable verdict. He also argued Simon and Simon, PC v. Align Technology, Inc. before the Ninth Circuit, which in October 2026 revived antitrust claims against the maker of Invisalign. Mr. Davis regularly writes amicus briefs on behalf of the American Antitrust Institute in matters pending before the U.S. Supreme Court and federal appellate and trial courts.

Mr. Davis is an accomplished antitrust litigator at trial, at class certification, and on appeal. He was a member of the trial team in Innovative Health, LLC v. Biosense Webster, Inc. (C.D. Cal.), in which a jury found that Biosense Webster, a Johnson & Johnson subsidiary, engaged in anticompetitive conduct in the market for cardiac catheters. The court trebled the $147 million jury verdict to a $442 million judgment and entered a permanent injunction in a case that promises to reshape the healthcare industry, promote competition, and reduce healthcare costs. He has briefed and argued class certification in many of the nation’s leading antitrust class actions, including In re Capacitors Antitrust Litigation, Le v. Zuffa, LLC (UFC), and In re Restasis Antitrust Litigation. The American Antitrust Institute has honored his work with its award for Outstanding Antitrust Litigation Achievement in Private Law Practice four times: for Le v. Zuffa, LLC (2025), Innovative Health, LLC v. Biosense Webster, Inc. (2025), Fusion Elite All Stars v. Varsity Brands, LLC (2024), and In re Capacitors Antitrust Litigation (2023). He also received a CLAY California Attorney of the Year Award in Antitrust in 2016 for his work in In re Cipro Antitrust Litigation. Mr. Davis is the Vice Chair of the American Antitrust Institute’s board, co-organizes AAI’s annual Private Antitrust Enforcement Conference with Eric Cramer, serves on the Steering Committee of the AAI Appellate Project, and formerly chaired the Policy Task Force of the Committee to Support Antitrust Laws (COSAL).

Mr. Davis is also a leading authority on ethics in class actions and complex litigation. He is a Research Professor at the University of California College of the Law, San Francisco (UC Law SF), where he is associated with the Center for Litigation and Courts and organizes an annual conference on complex litigation ethics. He also organizes and moderates an annual panel on ethics at the American Bar Association’s National Institute on Class Actions and speaks frequently on the topic. He is the lead author and editor of Class Actions and Other Complex Litigation: Ethics (LexisNexis, 2026 and 2023), the first treatise dedicated to ethical issues in class actions and multidistrict litigation, which he co-authored and co-edited with Berger Montague Shareholder Candice Enders, and Associates Julie Pollock and Jessica Siegel. Mr. Davis previously taught at the University of San Francisco School of Law, where he directed its Center for Law and Ethics.

Mr. Davis has also taught at the Willamette University College of Law and the Georgetown University Law Center. He has testified before Congress on matters related to civil procedure and has presented on private antitrust enforcement before the U.S. Department of Justice and the Federal Trade Commission. His scholarship has been cited by multiple federal appellate and trial courts, and he has published more than thirty articles and book chapters on antitrust, civil procedure, class certification, legal ethics, and legal philosophy. He also co-authors with Rose Clark an annual empirical study of antitrust class actions in federal court; the most recent edition is the 2025 Annual Antitrust Report: Class Actions in Federal Court. He presents regularly at scholarly and professional conferences around the world on AI, aggregate litigation, civil procedure, and ethics. Much of his recent work addresses artificial intelligence and the law, including his forthcoming book, Unnatural Law: AI, Consciousness, Ethics, and Legal Theory (Cambridge University Press). His article “Defying Conventional Wisdom: The Case for Private Antitrust Enforcement,” 48 Ga. L. Rev. 1 (2013), won the 2014 award for best academic article from the George Washington University Law School and the Institute on Competition Law. Mr. Davis graduated from N.Y.U. School of Law, where he won the Frank H. Sommer Memorial Award for top general scholarship and achievement in his class, served as Senior Articles Editor of the N.Y.U. Law Review, and was elected to the Order of the Coif. After law school, he clerked for Judge Patrick E. Higginbotham of the U.S. Court of Appeals for the Fifth Circuit. He was a partner at Lieff Cabraser Heimann & Bernstein, LLP before entering full-time legal academia, and he joined the Firm in 2022.

Prominent Judgments & Settlements

  • Harrow v. Department of Defense, No. 23-21 (U.S.) (argued and won a unanimous 9-0 decision, May 16, 2024)
  • Innovative Health, LLC v. Biosense Webster, Inc. (9th Cir.) (won reversal of summary judgment); (C.D. Cal.) ($442 million judgment, trebling the $147 million jury verdict, and a permanent injunction)
  • Simon and Simon, PC v. Align Technology, Inc. (9th Cir.) (argued the appeal; Ninth Circuit revived antitrust claims, October 2026)
  • In re Capacitors Antitrust Litigation (N.D. Cal.) (direct purchaser plaintiffs) (briefed and argued motion to dismiss, Daubert, and class certification; participated in expert hearing and trial) (settlements of $440 million with a few defendants remaining)
  • In re Cipro Antitrust Litigation (Cal. S. Ct.; San Diego Sup. Ct.) (end purchaser plaintiffs) (briefed Actavis issues before the California Supreme Court and participated in trial preparation) (settled for $399 million)
  • High-Tech Employee Antitrust Litigation (N.D. Cal.) (participated in preparing expert reports and briefing class certification) (settled for over $400 million)
  • Truck Card Antitrust Litigation (E.D. Pa.) (direct purchaser plaintiffs) (briefed and argued at class certification hearing) (settled for $130 million)
  • In re Lidoderm Antitrust Litigation (N.D. Cal.) (end purchaser plaintiffs) (briefed and argued class certification) (settled for $105 million)
  • Castro v. Sanofi Pasteur Inc. (D.N.J.) (direct purchaser plaintiffs) (briefed motion to dismiss, Daubert, and class certification) (settled for $61.5 million)
  • UFC Antitrust Litigation (D. Nev.) (briefed motion to dismiss; briefed, argued, and participated in live expert hearing on class certification)
  • In re Restasis Antitrust Litigation (E.D.N.Y.) (end purchaser plaintiffs) (argued and participated in live expert hearing on class certification)
  • Carfax Antitrust Litigation (2d Cir.) (direct purchaser plaintiffs) (participated in briefing and argued the appeal)
  • Varsity Antitrust Litigation (W.D. Tenn.) (direct purchaser plaintiffs) (briefed opposition to motion to dismiss; working with experts on class certification and merits)
  • Generic Drugs Antitrust Litigation (E.D. Pa.) (end purchaser plaintiffs) (working with experts on class certification and merits)
  • In re Packaged Seafood Antitrust Litigation (S.D. Cal.) (commercial food preparers) (briefed and prepared expert reports for class certification)

Magnetic Iron Oxide Antitrust Litigation (N.D. Cal.) (direct purchaser plaintiffs) (briefed and argued motion to dismiss)

Professional Leadership

  • Vice Chair and Board Member, American Antitrust Institute
  • Former Chair, Policy Task Force, Committee to Support Antitrust Laws (COSAL)
  • Co-Organizer (with Eric Cramer), AAI Annual Private Antitrust Enforcement Conference
  • Organizer and Moderator, annual ethics panel, ABA National Institute on Class Actions

Speaking Engagements

“Integrity Under the Neon Lights: Going All-In on Professional Responsibility in Las Vegas,” ABA Litigation Section (October 2026).

Honors & Awards

Publications

  • Class Actions and Other Complex Litigation: Ethics, LexisNexis (2026 ed.) (lead author and editor, with Candice Enders, Julie Pollock, and Jessica Siegel)
    • Unnatural Law: AI, Consciousness, Ethics, and Legal Theory, Cambridge University Press (forthcoming)
    • “2025 Annual Antitrust Report: Class Actions in Federal Court,” UC Law SF (2026) (with Rose Clark)
    • “Antitrust Annual Report: Class Actions in Federal Court,” annual reports for 2018–2024, Univ. of San Francisco and UC Law SF Research Papers (2019–2025) (with Rose Clark). Read more here.
    • “Complex Litigation Ethics as Distinct,” Hastings Law Journal (2023)
    • “Complex Litigation Funding: Ethical Problem or Ethical Solution?,” 74 Hastings L.J. 1459 (2023) (with W. Bradley Wendel)
    • “The Ethics of Defense Counsel’s Communications with Absent Class Members Before Class Certification,” 74 Hastings L.J. 1331 (2023) (with Candice Enders)
    • “Of Robolawyers and Robojudges,” Hastings Law Journal (2022)
    • “Artificial (Complex) Litigation,” Hastings Law Journal (2022)
    • “Antitrust as Antiracism: Antitrust as a Partial Cure for Systemic Racism (and Other Systemic ‘Isms’),” The Antitrust Bulletin (2021) (with Eric L. Cramer, Reginald L. Streater, and Mark R. Suter)
    • “The Critical Role of Private Antitrust Enforcement in the United States: Commentary on 2020 Antitrust Annual Report,” American Antitrust Institute (2021) (with Laura M. Alexander, Randy Stutz, and Diana L. Moss)
    • “AI, Ethics, and Law: A Possible Way Forward” (2021)

    Read more of Mr. Davis’s publications here on SSRN.

In the News

  • Paramount Case Underscores California Court’s Antitrust Prowess, Bloomberg Law (July 20, 2026). Read more here.
  • DOJ Antitrust Chief’s Exit Shakes Up Private Litigants, States, Bloomberg Law (February 13, 2026). Read more here
Contact UsFree Case Evaluation

"*" indicates required fields

By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages. We reserve the right to collect, retain and use the data you provide.

Admissions

California
New York
Supreme Court of the U.S.
California Supreme Court
U.S. District Courts:

  • Northern District of California
  • Central District of California
  • District of Colorado
  •  USCA 9th Circuit
  • USCA 8th Circuit
  •  USCA 4th Circuit
  • USCA 1st Circuit
  • USCA 3rd Circuit
  • USCA 2nd Circuit
  • USCA 7th Circuit
  • USCA Federal Circuit